The 4th World Congress of
Biopharm Industry Development (BID-2025)
Theme: Bridging Global High-end Talents, Empowering Industrial Innovation
Time: September 24-26, 2025
Venue: Fengxian, Shanghai, China
Tentative Program |
|
Stream 1: Main Conference |
|
A. Opening Ceremony B. World PharmLeadership Forum-Plenary Lectures C. High-end Dialog |
|
Stream 2: Parallel Forums |
|
Forum 1: Cutting-Edge Drug Discovery Technologies |
|
Track 1-1: AI and Machine Learning in Drug Discovery |
Track 1-2: High-Throughput Screening |
Track 1-3: Single Cell Technologies and Spatial Omics |
Track 1-4: Organs-on-Chips and 3D Cell Culture Models |
Track 1-5: Quantum Computing in Drug Discovery |
|
Forum 2: Drug Discovery Chemistry Innovation |
|
Track 2-1: New Target Selection and Validation |
Track 2-2: Hit to Lead Identification and Lead Optimization |
Track 2-3: ADME and Pharmacokinetics |
Track 2-4: Natural Products and Traditional Medicine |
Forum 3: Novel Drug Delivery Technologies and Systems |
|
Track 3-1: Nanotechnology in Drug Delivery |
Track 3-2: Smart Drug Delivery Systems |
Track 3-3: Wearable and On-Body Drug Delivery Systems |
Track 3-4: Biodegradable Drug Delivery Systems |
Track 3-5: Personalized Drug Delivery |
|
Forum 4: Gene and Cell Therapy Innovation & Development |
|
Track 4-1: Cutting-Edge Gene Editing Tools and Techniques |
Track 4-2: Gene Therapy Target Identification |
Track 4-3: Next Generation RNA Therapy |
Track 4-4: Gene Therapy for Medical Unmet Major Diseases |
Track 4-5: CAR-T Cell Therapies |
Track 4-6: TCRT, CAR-NK and Tumor-infiltrating Lymphocyte (TIL) |
Track 4-7: Stem Cells and Regenerative Medicine |
Track 4-8: Cell Therapy for Major Diseases |
Forum 5: Next Generation Protein and Peptide Drugs |
|
Track 5-1: Protein Drugs Design & Engineering |
Track 5-2: PDC |
Track 5-3: Emerging PROTACs, Molecular Glues, and New Degrader Modalities |
Track 5-4: GLP-1 |
Track 5-5: Engineered Cytokines |
Track 5-6: VEGF and Angiogenesis Inhibitors |
Forum 6: Antibody, Vaccine and Biotherapeutics |
|
Track 6-1: Novel Antibody Discovery and Antibody-Based Therapy |
Track 6-2: ADC |
Track 6-3: Monoclonal Antibodies (mAbs) and Bispecific Antibodies (BsAbs) |
Track 6-4: Next-Generation Vaccines |
Track 6-5: Advanced Immunotherapy |
|
Forum 7: Pharmaceutical Process Development & Manufacturing |
|
Track 7-1: Novel Cell Lines, Cell Cultures and Purification Technologies |
Track 7-2: Smart Pharmaceutical Manufacturing |
Track 7-3: Additive Manufacturing (3D Printing) |
Track 7-4: Sustainability and Green Manufacturing |
Track 7-5: QC/QA & Bioanalysis |
Track 7-6: Outsourcing of Drug Development and |
Track 7-7: New Biosimilars and Biobetters |
|
Forum 8: Frontier Research in Drug Discovery |
|
Track 8-1: Pharmacogenomics and Personalized Medicine |
Track 8-2: Epigenetics in Drug Discovery |
Track 8-3: Bioinformatics and Computational Biology in Drug Discovery |
Track 8-4: The Microbiome-based Drug Discovery |
Track 8-5: Antimicrobial Resistance |
|
Forum 9: Clinical Research & Applications |
|
Track 9-1: Cancers/Tumors |
Track 9-2: CNS & Neurodegenerative Diseases |
Track 9-3: Infectious Diseases |
Track 9-4: Cardiovascular Diseases |
Track 9-5: Diabetes and Other Metabolic Disorders |
Track 9-6: Inflammation, Autoimmune & Immunological Diseases |
Track 9-7: Digestive System Diseases |
Track 9-8: Pharmacovigilance, Drug Safety and Risk Management |
Stream 3: Business and Career Development |
|
Stream 3-1: Project and Talent Business Docking Activities |
Stream 3-2: Project Roadshow and Investment & Financing Cooperation Meeting |
Stream 3-3: Roundtable Discussions |
Stream 3-4: Business Networking Dinner |
Stream 3-5: Biomedical Education and Training Workshop |
Stream 3-6: Frontier Posters of Pharmaceutical Industry |
Stream 3-7: New Technologies and Products Exhibition |
|
Stream 4: Cultural & Social Activities |
|
Activity 1: Welcome Banquet and Culture Performance |
Activity 2: Master Tours to Campus |
Activity 3: Field Trip to Industrial Parks |
Activity 4: Local Impression Tech-Tour |